Skip to main content

Advertisement

Log in

Radiographic patterns of relapse in glioblastoma

  • Case Report
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Glioblastoma (GBM) pathologically is defined as an infiltrative glioma and salvage therapy with bevacizumab is believed to increase the incidence of diffuse and distant invasion as assessed radiographically. Eighty adult patients with glioblastoma were treated with surgery followed by radiotherapy (RT) and concurrent and adjuvant temozolomide (TMZ). At first recurrence, 80 patients were treated with single agent bevacizumab. At time of progression, 57 patients were treated with bevacizumab and a cytotoxic chemotherapy, cytotoxic chemotherapy alone or on an investigational trial. Magnetic resonance imaging (MRI) were analyzed at four time points in each patient; at presentation, at first, second and third recurrence. Four patterns of radiographic disease were assessed, local (unifocal disease), distant (second lesion noncontiguous with primary lesion), multifocal (>2 lesions including leptomeningeal dissemination) and diffuse. At presentation 87.5% of glioblastoma were local, 6.25% distant, 3.75% multifocal and 2.5% diffuse. At first recurrence following progression on RT/TMZ and before initiation of bevacizumab, 80% were local, 7.5% distant, 6.25% multifocal (including 1 with CSF dissemination) and 6.25% diffuse. At second recurrence following progression on bevacizumab, 71.25% were local, 8.75% distant, 8.75% multifocal (2/7 with CSF dissemination) and 11.25% were diffuse. At third recurrence (57 patients evaluable), 71.25% were local, 7.0% distant, 7.0% multifocal and 14.0% were diffuse. Survival following progression on bevacizumab did not differ by pattern of radiographic recurrence. A majority of adult patients with GBM at diagnosis manifest MRI-defined local disease and maintain this pattern notwithstanding multiple recurrences and treatment with bevacizumab.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Eng J Med 352:987–996

    Article  CAS  Google Scholar 

  2. Vredenburgh JJ, Desjardins A, Herndon JE et al (2007) Bevacizumab plus irinotecan in recurrent glioblastoma. J Clin Oncol 25:4722–4729

    Article  CAS  PubMed  Google Scholar 

  3. Kreisl TN, Kim L, Moore K et al (2009) Phase II trial of single agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27:740–745

    Article  CAS  PubMed  Google Scholar 

  4. Friedman HS, Prados MD, Wen PY et al (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4723–4740

    Article  Google Scholar 

  5. Pope WB, Xia Q, Das A et al (2009) Patterns of progression in patients with glioblastoma at first or second relapse treated with bevacizumab alone or in combination with irinotecan in the BRAIN study. Neuro-Oncology 11:626 (abstract # 270)

    Google Scholar 

  6. Norden AD, Young GS, Setayesh K et al (2008) Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology 70:779–787

    Article  CAS  PubMed  Google Scholar 

  7. Quant EC, Norden AD, Drappatz J et al (2009) Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab. Neuro-Oncology 11:550–555

    Article  CAS  PubMed  Google Scholar 

  8. Oh J, Sahgal A, Tsao MT et al (2009) Patterns of recurrence of primary glioblastoma multiforme treated with chemoradiation in the temozolomide era. Neuro-Oncology 11:623 (abstract #257)

    Google Scholar 

  9. Iwamoto FM, Abrey LE, Beal PH et al (2009) Patterns of relapse and prognosis after bevacizumab failure in glioblastoma. Neurology 73:1200–1206

    Article  CAS  PubMed  Google Scholar 

  10. Gutin PH, Iwamoto FM, Beal K et al (2009) Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol 75(1):156–163

    Article  CAS  Google Scholar 

  11. Silbergeld DL, Rostomily RC, Alvord EC (1991) The causes of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neuro-Oncol 10:179–185

    Article  CAS  Google Scholar 

  12. Wen P, Macdonald DR, Reardon DA et al (2009) Proposal for an updated response assessment criteria for high-grade gliomas: radiology assessment for neuro-oncology: working group. J Clin Oncol 28:1963–1972

    Article  Google Scholar 

Download references

Conflict of interest statement

The author reports no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc C. Chamberlain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamberlain, M.C. Radiographic patterns of relapse in glioblastoma. J Neurooncol 101, 319–323 (2011). https://doi.org/10.1007/s11060-010-0251-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0251-4

Keywords

Navigation